IONIS PHARMACEUTICALS INC (IONS)
US4622221004 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -384.79M | -366.29M | -269.70M | -28.60M | -479.70M | |||
| Depreciation Amortization | 12.84M | 12.85M | 16.70M | 17.90M | 15.50M | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | 0.00 | 341.70M | |||
| Change In Working Capital | -67.78M | -77.26M | 7.60M | -113.80M | -73.60M | |||
| Interest Paid | 6.51M | 6.51M | 2.90M | 4.80M | 6.20M | |||
| Taxes Paid | 48.05M | 48.33M | 5.00M | 0.00 | 25.90M | |||
| Other non cash items | 116.28M | 123.18M | -29.00M | 155.40M | 232.00M | |||
| OPERATING CASH FLOW | -323.45M | -307.51M | -274.40M | 30.80M | 35.90M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -17.80M | -23.80M | -15.70M | -12.00M | -35.10M | |||
| Other Investing Activity | 205.48M | -190.32M | -246.90M | 206.90M | 309.60M | |||
| INVESTING CASH FLOW | 187.58M | -214.13M | -262.60M | 194.90M | 274.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 86.86M | 86.90M | -50.70M | 313.60M | 0.00 | |||
| Stock Issued/Repurchased | 70.45M | 49.44M | 6.40M | 101.30M | -38.50M | |||
| Other Financing Activity | 18.14M | 507.74M | -11.00M | -169.00M | -558.10M | |||
| FINANCING CASH FLOW | 175.55M | 644.08M | -55.30M | 245.90M | -596.60M | |||
| Exchange Rate Effect | 138.00K | 352.00K | -400.00K | -100.00K | 600.00K | |||
| CHANGE IN CASH | 39.82M | 122.79M | -592.70M | 471.50M | -285.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -323.45M | -307.51M | -274.40M | 30.80M | 35.90M | |||
| Capital Expenditure | -17.80M | -23.80M | -15.70M | -12.00M | -35.10M | |||
| FREE CASH FLOW | -341.25M | -331.32M | -290.10M | 18.80M | 800.00K | |||
All data in USD